862669-17-8

Basic information

• Product Name: 1,1-dimethylethyl 4-methyl-1-oxa-6-azaspiro[2.5]octane-6-carboxylate
• Synonyms: 1,1-dimethylethyl 4-methyl-1-oxa-6-azaspiro[2.5]octane-6-carboxylate
• CAS NO: 862669-17-8
• Molecular Weight: 227.304
• Mol File: 862669-17-8.mol

Chemical Properties

• CAS DataBase Reference: 1,1-dimethylethyl 4-methyl-1-oxa-6-azaspiro[2.5]octane-6-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1-dimethylethyl 4-methyl-1-oxa-6-azaspiro[2.5]octane-6-carboxylate(862669-17-8)
• EPA Substance Registry System: 1,1-dimethylethyl 4-methyl-1-oxa-6-azaspiro[2.5]octane-6-carboxylate(862669-17-8)

Safety Data

• Hazardous Substances Data: 862669-17-8(Hazardous Substances Data)

Upstream product

• 181269-69-2 tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate 
• 1774-47-6 trimethylsulfoxonium iodide 
• 336182-47-9 tert-butyl 3-methyl-4-methylidenepiperidine-1-carboxylate 

Downstream Products

• 862669-18-9 C₁₈H₂₅Cl₂NO₃ 

Relevant articles and documents

FATTY ACID SYNTHASE INHIBITORS

This invention relates to novel spirocyclic piperidines according to Formula (I) which are inhibitors of fatty acid synthase (FAS), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.

Piperdine derivatives useful as CCR3 antagonists

The use of CCR3 antagonists of the formula I or a pharmaceutically acceptable salt thereof for the treatment of asthma is disclosed, as well as novel compounds of the formula II, pharmaceutical compositions comprising them, and their use in the treatment